The Latin America, Middle East and Africa Myomectomy Market is expected to witness market growth of 14.7% CAGR during the forecast period (2020-2026).
The growing number of patients who are suffering from uterine fibroids and related conditions, the rising number of minimal invasive procedures, and the increasing adoption of advanced technological devices for effective and safe treatment, myomectomy procedures are adopted and they are the main factors likely to drive the market. Patients who are suffering from the problem of uterine fibroid signify a huge market growth. A myomectomy is the best effective and efficient way to treat fibroids and concurrently preserves the uterus. There are many ways to perform a myomectomy procedure and they depend on the location and size of the fibroids.
The introduction of technologically advanced products in the market due to the more adoption of myomectomy procedures for the removal of uterine fibroids is expected to boost the growth of the market. Advancements in technology and its increased implementation in healthcare industries, for example, the introduction of robotically assisted myomectomy procedures which is an incision-less surgery and has minimal side effects that is why it is widely used for fibroids treatment. As compared to the open abdominal myomectomy surgery, with that of robotic myomectomy, it is proved that patient experience less blood loss and also has fewer complication rates, patients also need to have a shorter hospital stay and resume normal activities more quickly.
Based on Type, the market is segmented into Abdominal Myomectomy, Hysteroscopic Myomectomy and Laparoscopic Myomectomy. Based on Product, the market is segmented into Harmonic Scalpel, Laparoscopic Sealer, Laparoscopic Power Morcellators and Other Products. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Johnson and Johnson, Hologic, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, ConMed Corporation, Intuitive Surgical, Inc., The Cooper Companies, Inc., and Minerva Surgical, Inc.
Scope of the Study
Market Segmentation:
By Type
By Product
By Country
Companies Profiled
Unique Offerings from the Publisher
The growing number of patients who are suffering from uterine fibroids and related conditions, the rising number of minimal invasive procedures, and the increasing adoption of advanced technological devices for effective and safe treatment, myomectomy procedures are adopted and they are the main factors likely to drive the market. Patients who are suffering from the problem of uterine fibroid signify a huge market growth. A myomectomy is the best effective and efficient way to treat fibroids and concurrently preserves the uterus. There are many ways to perform a myomectomy procedure and they depend on the location and size of the fibroids.
The introduction of technologically advanced products in the market due to the more adoption of myomectomy procedures for the removal of uterine fibroids is expected to boost the growth of the market. Advancements in technology and its increased implementation in healthcare industries, for example, the introduction of robotically assisted myomectomy procedures which is an incision-less surgery and has minimal side effects that is why it is widely used for fibroids treatment. As compared to the open abdominal myomectomy surgery, with that of robotic myomectomy, it is proved that patient experience less blood loss and also has fewer complication rates, patients also need to have a shorter hospital stay and resume normal activities more quickly.
Based on Type, the market is segmented into Abdominal Myomectomy, Hysteroscopic Myomectomy and Laparoscopic Myomectomy. Based on Product, the market is segmented into Harmonic Scalpel, Laparoscopic Sealer, Laparoscopic Power Morcellators and Other Products. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Johnson and Johnson, Hologic, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, ConMed Corporation, Intuitive Surgical, Inc., The Cooper Companies, Inc., and Minerva Surgical, Inc.
Scope of the Study
Market Segmentation:
By Type
- Abdominal Myomectomy
- Hysteroscopic Myomectomy
- Laparoscopic Myomectomy
By Product
- Harmonic Scalpel
- Laparoscopic Sealer
- Laparoscopic Power Morcellators
- Other Products
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Medtronic PLC
- Stryker Corporation
- Johnson and Johnson
- Hologic, Inc.
- Karl Storz SE & Co. KG
- B. Braun Melsungen AG
- ConMed Corporation
- Intuitive Surgical, Inc.
- The Cooper Companies, Inc.
- Minerva Surgical, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Myomectomy Market by Type
Chapter 4. LAMEA Myomectomy Market by Product
Chapter 5. LAMEA Myomectomy Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Medtronic PLC
- Stryker Corporation
- Johnson and Johnson
- Hologic, Inc.
- Karl Storz SE & Co. KG
- B. Braun Melsungen AG
- ConMed Corporation
- Intuitive Surgical, Inc.
- The Cooper Companies, Inc.
- Minerva Surgical, Inc.
Methodology
LOADING...
